ABC57 Article Rating
Follow

Appeals court says abortion pill mifepristone should remain on the market but rules in favor of limiting access

Aug 17, 2023 View Original Article
  • Bias Rating

    16% Somewhat Conservative

  • Reliability

    60% ReliableFair

  • Policy Leaning

    36% Medium Conservative

  • Politician Portrayal

    44% Negative

Bias Score Analysis

The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.

Sentiments

Overall Sentiment

N/A

  •   Liberal
  •   Conservative
SentenceSentimentBias
Unlock this feature by upgrading to the Pro plan.

Bias Meter

Extremely
Liberal

Very
Liberal

Moderately
Liberal

Somewhat Liberal

Center

Somewhat Conservative

Moderately
Conservative

Very
Conservative

Extremely
Conservative

-100%
Liberal

100%
Conservative

Bias Meter

Contributing sentiments towards policy:

62% : Elrod's opinion also embraced claims about mifepristone's risks, put forward by anti-abortion doctors challenging the FDA approval, even though those characterizations had been widely rebuked by mainstream medical groups.
59% :The lawsuit was filed in a Texas federal court in November by anti-abortion doctors and medical organizations seeking to pull mifepristone - the first drug in the two-pill regimen for terminating pregnancies - from the market.
45% : The ruling is the latest twist in the dramatic case, which is the most consequential legal battle over abortion since the Supreme Court last summer overturned the 1973 Roe v. Wade precedent that protected abortion rights nationwide.
43% : The case was filed in a remote Texas court division that guaranteed it would be heard by Kacsmaryk, an appointee of former President Donald Trump who worked for a conservative religious liberty organization before joining the bench and whose personal hostility toward abortion has been reported by The Washington Post.Kacsmaryk embraced whole-heartedly the arguments put forward by the abortion opponents, with an April 7 ruling that would have suspended mifepristone's approval but that was not allowed to take effect.
43% : Planned Parenthood called on the Supreme Court to "reject this clearly baseless and political attempt to interfere with our ability to get health care."
42% : While the ruling has no immediate impact on access to medication abortion drugs, it sets the stage for the Supreme Court to yet again weigh in on abortion.
34% : Since Roe's reversal, abortion providers in states where abortion remains legal have relied upon the availability of abortion pills to relieve the burdens on clinics that have been flooded with patients from regions of the county where abortion has been severely restricted.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.

Copy link